Ezetimibe Evaluation as a Treatment of Hyperlipidemia in Patients with Covid-19: A Case Report

Volume 20 No 6 (2022)

Yasmine Farouk Shamseldin, Amal Kamal Hussein , Eman Mohamed Sadek, Ahmed Abuelhana, Hassan Shalaby, Houssam Mowafi

DOI: 10.14704/nq.2022.20.6.NQ22024

Abstract

The current coronavirus disease known as (COVID-19) which has been declared by the World Health Organization (WHO) in December 2019 as a global health emergency and then after as a pandemic, represents a big challenge to all healthcare systems worldwide specially for managing the infection among patients who are hospitalized, acutely ill or elderly

Keywords

Ezetimibe, Covid-19, Case Study, Hyperlipidemias

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.